NCT03915951 2025-11-17An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung CancerPfizerPhase 2 Completed98 enrolled 18 charts 1 FDA
NCT04543188 2025-10-23A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementPfizerPhase 1 Terminated65 enrolled 52 charts
NCT03271047 2022-01-04Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS MutationPfizerPhase 2 Completed75 enrolled 17 charts
NCT05097378 2021-10-28PREMIUMCambridge University Hospitals NHS Foundation TrustPhase 2 Unknown45 enrolled